Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 7/20 | 0.71 |
| ▸ | FUCA1 | P04066 | 5/20 | 0.52 |
| ▸ | GLA | P06280 | 3/20 | 0.52 |
| ▸ | GANC | Q8TET4 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | AGL | P35573 | 2/20 | 0.48 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.48 |
| ▸ | GBA1 | P04062 | 1/20 | 0.48 |
| ▸ | MAN2A1 | Q16706 | 1/20 | 0.46 |
| ▸ | MAN1B1 | Q9UKM7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19258270 | 0.98 | MGAM (0.73) | MGAMFUCA1GLAGANCGAA | |
| SCHEMBL13538449 | 0.98 | MGAM (0.73) | MGAMFUCA1GLAGANCGAA | |
| SCHEMBL17622803 | 0.98 | MGAM (0.73) | MGAMFUCA1GLAGANCGAA | |
| Radicamine B SCHEMBL2439078 | 0.83 | MGAM (1.00) | MGAMFUCA1GLAGANCGAA | |
| Radicamine B SCHEMBL8118948 | 0.83 | MGAM (1.00) | MGAMFUCA1GLAGANCGAA | |
| Radicamine B SCHEMBL13848027 | 0.83 | MGAM (1.00) | MGAMFUCA1GLAGANCGAA | |
| SCHEMBL8124155 | 0.81 | MGAM (0.72) | MGAMFUCA1GLAGANCGAA | |
| SCHEMBL8124475 | 0.81 | MGAM (0.72) | MGAMFUCA1GLAGANCGAA | |
| SCHEMBL830731 | 0.81 | MGAM (0.50) | MGAMGAAGBA1MAN2A1MAN1B1 | |
| SCHEMBL835907 | 0.81 | MGAM (0.50) | MGAMGAAGBA1MAN2A1MAN1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5051407-A | Viricides | BAYER AKTIENGESELLSCHAFT (DE) | 1991-09-24 | — | — | US | disclosed |
| EP-0315017-A2 | Use of 2-hydroxymethylene-3,4,5-trihydroxypiperidines as antiviral agents | BAYER AG (DE) | 1989-05-10 | — | — | EP | disclosed |
| US-4328233-A | α-Glucosidase inhibiting 2-hydroxymethyl-3,4,5-trihydroxy-piperidines | BAYER AKTIENGESELLSCHAFT (DE) | 1982-05-04 | — | — | US | disclosed |
| EP-0010745-A1 | 2-Hydroxymethyl-3,4,5-trihydroxy-piperidine derivatives, their preparation and medicaments containing them | BAYER AG (DE) | 1980-05-14 | — | — | EP | disclosed |